tm logo
NUVARA THERAPEUTICS
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 26 Apr 2024

Last Applicant/ Owned by

100 RIVER RIGE RIVE #206

NORWOO

US

02062

Serial Number

90469704 filed on 15th Jan 2021

Registration Number

N/A

Correspondent Address

Ryan M. KaiserAMIN WASSERMAN GURNANI LLP

549 W. Randolph St.Suite 400

Chicago,IL

60661

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NUVARA THERAPEUTICS

"THERAPEUTICS" Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorderRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds

Mark Details


Serial Number

No 90469704

Mark Type

No Service/Collective Mark

Attorney Docket Number

No EBS-0067-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Apr 2024NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE
26th Apr 2024SOU EXTENSION 5 GRANTE
26th Apr 2024SOU EXTENSION 5 ILE
26th Apr 2024SOU TEAS EXTENSION RECEIVE
24th Apr 2024TEAS CHANGE O CORRESPONENCE RECEIVE
24th Apr 2024ATTORNEY/OM.REP.REVOKE AN/OR APPOINTE
24th Apr 2024TEAS REVOKE/APP/CHANGE AR O ATTY/OM REP RECEIVE
20th Oct 2023NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE
18th Oct 2023SOU EXTENSION 4 GRANTE
18th Oct 2023SOU EXTENSION 4 ILE